WallStreetZenWallStreetZen

NASDAQ: ORGO
Organogenesis Holdings Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ORGO

Based on 1 analyst offering 12 month price targets for Organogenesis Holdings Inc

Min Forecast
$8.00+234.73%
Avg Forecast
$8.00+234.73%
Max Forecast
$8.00+234.73%

Should I buy or sell ORGO stock?

Based on 1 analyst offering ratings for Organogenesis Holdings Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model "Buy" agrees with analyst consensus with a "Strong Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their ORGO stock forecasts and price targets.

ORGO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-02-27

1 of 1

Forecast return on equity

Is ORGO forecast to generate an efficient return?

Company
14.21%
Industry
34.85%
Market
149.81%
ORGO's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ORGO forecast to generate an efficient return on assets?

Company
7.12%
Industry
14.99%
ORGO is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ORGO earnings per share forecast

What is ORGO's earnings per share in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$0.03-115.94%
Avg 2 year Forecast
$0.33+107.19%

ORGO revenue forecast

What is ORGO's revenue in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
$409.2M-27.46%
Avg 2 year Forecast
$516.7M-8.41%
ORGO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ORGO revenue growth forecast

How is ORGO forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
-27.46%
Industry
8.96%
Market
25.03%
ORGO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ORGO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ORGO vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
ORGO$2.39$8.00+234.73%Strong Buy
EOLS$4.64$15.50+234.05%Strong Buy
SIGA$4.94N/AN/A
CGC$0.95N/AN/A
EBS$8.19$12.00+46.52%Buy
View Top Pharmaceutical Stocks

Organogenesis Holdings Stock Forecast FAQ

Is Organogenesis Holdings Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ORGO) stock is to Strong Buy ORGO stock.

Out of 1 analyst, 1 (100%) are recommending ORGO as a Strong Buy, 0 (0%) are recommending ORGO as a Buy, 0 (0%) are recommending ORGO as a Hold, 0 (0%) are recommending ORGO as a Sell, and 0 (0%) are recommending ORGO as a Strong Sell.

If you're new to stock investing, here's how to buy Organogenesis Holdings stock.

What is ORGO's earnings growth forecast for 2026-2027?

(NASDAQ: ORGO) Organogenesis Holdings's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 46.54%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 1,670.09%.

Organogenesis Holdings's earnings in 2026 is $20,022,000.On average, 4 Wall Street analysts forecast ORGO's earnings for 2026 to be -$3,280,337, with the lowest ORGO earnings forecast at -$28,995,607, and the highest ORGO earnings forecast at $24,313,087.

In 2027, ORGO is forecast to generate $42,644,382 in earnings, with the lowest earnings forecast at $28,995,607 and the highest earnings forecast at $56,730,536.

What is ORGO's revenue growth forecast for 2026-2027?

(NASDAQ: ORGO) Organogenesis Holdings's forecast annual revenue growth rate of -27.46% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 8.96%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.03%.

Organogenesis Holdings's revenue in 2026 is $564,169,000.On average, 3 Wall Street analysts forecast ORGO's revenue for 2026 to be $52,642,335,387, with the lowest ORGO revenue forecast at $50,578,939,024, and the highest ORGO revenue forecast at $54,191,169,065.

In 2027, ORGO is forecast to generate $66,472,493,926 in revenue, with the lowest revenue forecast at $63,866,233,931 and the highest revenue forecast at $68,427,832,125.

What is ORGO's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: ORGO) forecast ROA is 7.12%, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 14.99%.

What is ORGO's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ORGO price target, the average ORGO price target is $8.00, with the highest ORGO stock price forecast at $8.00 and the lowest ORGO stock price forecast at $8.00.

The Wall Street analyst predicted that Organogenesis Holdings's share price could reach $8.00 by Feb 27, 2027. The average Organogenesis Holdings stock price prediction forecasts a potential upside of 234.73% from the current ORGO share price of $2.39.

What is ORGO's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: ORGO) Organogenesis Holdings's current Earnings Per Share (EPS) is $0.16. On average, analysts forecast that ORGO's EPS will be -$0.03 for 2026, with the lowest EPS forecast at -$0.23, and the highest EPS forecast at $0.19. In 2027, ORGO's EPS is forecast to hit $0.33 (min: $0.23, max: $0.44).

What is ORGO's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: ORGO) forecast ROE is 14.21%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.